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Introduction
This admission prevalence survey is part of the multicen-
ter study ATHOS (antibiotic therapy optimisation study).
ATHOS aims at collecting prevalence and incidence data
for nosocomial carriage of multi-drug resistant organisms
(MDROs) and to intervene in the inpatient and outpatient
setting.
Objectives
The aim of this admission prevalence survey was to
assess the rectal carriage of third generation cephalos-
porin-resistant enterobacteria (3GCREB) in patients on
hospital admission and to perform risk factor analyses for
3GCREB carriage.
Methods
In 2014, we recruited adult patients within 72 h of admis-
sion to non-intensive care units in six German university
hospitals. We obtained rectal swabs that were screened for
3GCREB. Each patient was asked to answer a short ques-
tionnaire on potential risk factors for colonisation with
MDROs. Univariable and multivariable risk factor analyses
were performed on preliminary data to identify those fac-
tors that were associated with 3GCREB prevalence.
Results
Of the 4372 patients included, 423 patients were
3GCREB carriers (admission prevalence of 9.7%). Most
isolates were Escherichia coli (76.8%). Surprisingly,
41.9% of all 3GCREB isolates were additionally resistant
to fluoroquinolones. Only two patients (<0.1%) were
colonised with carbapenemase-producing enterobacteria.
Multivariable analysis associated the following risk
factors with 3GCREB colonisation: centre, previous
MDRO colonisation (OR = 2.16, p<0.001), antibiotic use
(OR=2.08, p<0.001), travel abroad (OR=1.26, p=0.033)
and management of gastroesophageal reflux disease
(GERD) (OR=1.1, p=0.047).
Conclusion
To our knowledge, this is one of the largest admission pre-
valence surveys of 3GCREB in Germany. Interestingly,
medical management of GERD and the specific centres to
which the patients where admitted proved to be additional
risk factors for 3GCREB colonisation on hospital admis-
sion. Whether information present on admission will be
useful to improve prediction of nosocomial colonisation
and infection as well as target infection control measures
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